Search

Your search keyword '"OraSure Technologies Inc."' showing total 3,227 results

Search Constraints

Start Over You searched for: Descriptor "OraSure Technologies Inc." Remove constraint Descriptor: "OraSure Technologies Inc."
3,227 results on '"OraSure Technologies Inc."'

Search Results

1. Q3 2024 OraSure Technologies Inc Earnings Call - Final

2. World Health Organization prequalifies OraQuick HCV self-test for hepatitis C virus

3. Finding top talent is challenging for Lehigh Valley companies

4. OraSure supports HIV testing initiatives for National HIV Testing Day

5. Krystal Biotech, Virtu, StepStone, Cactus Inc., Tidewater to join S&P 600

6. OraSure Reports Q3 '24 Revenue of $39.9 Million

7. 8-K: ORASURE TECHNOLOGIES INC

8. Carrie Eglinton Manner

9. OraSure Technologies invests in Sapphiros and secures strategic distribution rights

10. Orasure Technologies Inc. Files SEC Form SC 13G, Statement of Beneficial Ownership By Certain Investors: (Oct. 4, 2024)

11. Slone Partners Places Jack Kenny on Board of Directors at OraSure Technologies

12. OraSure Technologies Elects Jack Kenny to the Board of Directors

13. OraSure Technologies Elects Jack Kenny to the Board of Directors

14. OraSure Technologies Elects Jack Kenny to the Board of Directors

15. Drug Abuse Testing Market Report By Drug Type, Product & Services, Sample Type, End Users Countries and Company Analysis

16. OraSure Reports Q2 ’24 Revenue of $54.3 Million

17. Switzerland : WHO prequalifies the first self-test for hepatitis C virus

18. Switzerland : WHO prequalifies first self-test for hepatitis C virus

19. Switzerland : WHO prequalifies the first hepatitis C self-diagnosis test

20. WHO PREQUALIFIES FIRST SELF-TEST KIT FOR HEPATITIS C VIRUS

21. OraSure Technologies Inc to Discuss Its Strategic Relationship with Sapphiros Call - Final

22. Orasure Technologies Inc. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Jul. 8, 2024)

23. OraSure Technologies Supports National HIV Testing Day

24. Orasure Technologies Inc. Files SEC Form 8-K, Current Report: (Nov. 6, 2024).

25. Orasure Technologies Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 6, 2024).

26. Patent Issued for Reagents, methods, and systems for detecting therapeutic agents to monitor adherence to nucleoside reverse transcriptase inhibitor metabolites (USPTO 12099056).

27. Gov Shapiro announces ten-year economic strategy

28. OraSure elects McMahon to its board of directors

29. Q3 2023 OraSure Technologies Inc Earnings Call - Final

30. Researchers from Manchester University NHS Foundation Trust Discuss Research in Cervical Cancer (Two self-sampling strategies for HPV primary cervical cancer screening compared with clinician-collected sampling: an economic evaluation)

31. NOWDiagnostics Greets Dr. Stephen S. Tang as Chairman of the Board

32. NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

33. NOWDiagnostics Welcomes Dr. Jody Douglas Berry as Chief Scientific Officer

34. FORM 8-K: ORASURE TECHNOLOGIES INC Files Current Report (Jan 04, 2024)

35. Orasure Technologies Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Jun. 6, 2024)

36. Orasure Technologies Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 16, 2024)

37. Orasure Technologies Inc. Files SEC Form ARS, Annual Report To Security Holders: (Apr. 4, 2024)

38. Orasure Technologies Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Apr. 4, 2024)

39. Orasure Technologies Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements: (Apr. 3, 2024)

40. Orasure Technologies Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 28, 2024)

41. Orasure Technologies Inc. Files SEC Form PRE 14A, Other Preliminary Proxy Statements: (Mar. 22, 2024)

42. OraSure Technologies gets US FDA approval for ORAcollectDx saliva collection device for OTC use

43. OraSure receives general clearance for its ORAcollect Dx device

44. OraSure's COVID-19 Rapid Test available in Amazon's online store

45. Carrie Eglinton Manner

46. OraSure to Participate in Upcoming Investor Conferences

47. 8-K: ORASURE TECHNOLOGIES INC

48. Orasure Technologies Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Feb. 5, 2024)

49. Study Findings on COVID-19 Published by Researchers at OraSure Technologies Inc. [Development and Clinical Performance of InteliSwab[superscript]® COVID-19 Rapid Test: Evaluation of Antigen Test for the Diagnosis of SARS-CoV-2 and Analytical ...]

50. Orasure Technologies Inc. Files SEC Form SC 13G/A, Statement of Acquisition of Beneficial Ownership By Individuals: (Jan. 22, 2024)

Catalog

Books, media, physical & digital resources